Was Foresee Pharmaceuticals hit by ransomware?

Foresee Pharmaceuticals was listed by the Incransom ransomware operation (Taiwan), and stolen data was published on the group's leak site. Darkfield tracks this disclosure with the original leak post, screenshot and group context.

Who is the Incransom ransomware group?

Incransom is a ransomware operator tracked by Darkfield. See the full operator dossier for its known victims, sectors targeted, IOCs and leak-site infrastructure.

What data was leaked in the Foresee Pharmaceuticals breach?

Incransom published data attributed to Foresee Pharmaceuticals. Darkfield captured the leak post and a screenshot of the listing.

Ransomware victim disclosure

← All victims

Foresee Pharmaceuticals

Claimed by Incransom · listed 4 hours ago

Today

Age

since listed · data leaked

Status timeline

ListedAug 18, 2026
Data leakeddate unknown

At a glance

Group: Incransom
Status: Data leaked
Country: Taiwan
Sector: Healthcare
Listed on leak site: Aug 18, 2026

About the victim

AI dossier — public-source company profile

Foresee Pharmaceuticals Co., Ltd. is a pharmaceutical company based in Taiwan operating the domain foreseepharma.com. The company is engaged in drug development and manufacturing, working with partners including Accord BioPharma, Intas Pharmaceuticals, and Primevera Therapeutics on multiple development projects.

Industry: Pharmaceutical Manufacturing & Drug Development

Attack summary

Severity: critical — Confirmed exfiltration of highly regulated pharmaceutical intellectual property including FDA/EMA submissions, clinical trial data, and drug development files for multiple candidates. Exposure of regulatory documentation and clinical study data constitutes breach of sensitive health/research information with significant impact on drug development timelines and competitive position.

incransom claims to have exfiltrated approximately 1.2 TB of data from Foresee Pharmaceuticals, including Drug Master Files, ASMF documentation, FDA/EMA regulatory submissions, R&D materials, financial statements, and clinical study reports across multiple drug candidates in development.

critical

Data the group says was taken

AI dossier — extracted from the leak post

Drug Master Files (DMF)
ASMF (Active Substance Master File)
FDA regulatory submissions
EMA regulatory submissions
R&D documentation
Financial statements
Clinical study reports
Drug development project files (CAMCEVI, SIF, Caspian, NCE, Aderamastat, Linvemastat, FP-045, FP-016, FP-018, FP-014)

What the group claims

Foresee Pharmaceuticals Co., Ltd. https://www.foreseepharma.com Total leak: 1,2TB Leak includes: Drug Master File, ASMF, FDA/EMA, R&D, Financial statements, Clinical study reports and other confidential information. Projects: CAMCEVI, SIF, Casppian, NCE, Aderamastat, Linvemastat, FP-045, FP-016, FP-018, FP-014... Partners: Accord BioPharma, Intas Pharmaceuticals, Primevera Therapeutics, Accord Healthcare... Type of information: Confidential

Sources

Source

Indexed 4 hours ago

This page surfaces a public ransomware disclosure indexed by Darkfield. Original posts come from the operator's own leak site; we cross-check against ransomware.live, RansomLook and RansomWatch where applicable. Share this URL freely.

Is this your supplier? Your competitor? You?

Pro plans monitor your domain, corporate emails, and crypto wallets across every new ransomware leak-site post, breach dump and Telegram callout — alerts within 5 minutes.

Disclosure context

About Incransom

Incransom is a ransomware group that emerged in August 2023, operating with primarily financial motivations as evidenced by their targeting of high-value sectors across multiple developed nations. The group's origin and specific affiliations remain undocumented by major threat intelligence organizations, though their operational patterns suggest they likely operate independently rather than as a ransomware-as-a-service model. With 734 documented victims, Incransom has demonstrated a preference for targeting organizations in the United States, Canada, United Kingdom, Germany, and Australia, with particular focus on healthcare, technology, business services, and manufacturing sectors, though their attack methodology and specific technical capabilities have not been extensively documented by established security researchers or government agencies. The group's notable campaigns and specific high-profile victims have not been publicly detailed by CISA, FBI, Mandiant, or other reputable threat intelligence sources, suggesting either operational security effectiveness or limited visibility into their most significant operations. Based on available intelligence, Incransom appears to remain active as of recent reporting periods, though comprehensive analysis of their current operational status requires additional documentation from established threat intelligence sources. The group has been linked to 1,761 public disclosures across our corpus. First observed on a leak site on September 9, 2021; most recent post August 18, 2026. The operation is currently active.

Also tracked as: inc ransom, INC.

Timeline of this disclosure

August 18, 2026Foresee Pharmaceuticals listed by Incransomon the group's public leak site

Other recent disclosures by Incransom

Incransom has been linked to 1,761 public victims on Darkfield. A sample of the most recent:

See the full Incransom dossier →

Sector and geography

This disclosure adds to ransomware activity in the Healthcare sector, which has 2,608 disclosures indexed across all operators we track. Geographically, Foresee Pharmaceuticals is reported in Taiwan, a country with 58 ransomware disclosures in our corpus.

If your organisation is affected

A listing by Incransom means Foresee Pharmaceuticals appeared on a ransomware extortion site and data attributed to it has been published. If this is your organisation, or a supplier you depend on, the priority is to confirm the intrusion and contain it before the window to act closes.

Engage your incident-response team and preserve forensic evidence before remediating — do not wipe affected systems first.
Force a password reset and revoke active sessions for exposed accounts; rotate any credentials, API keys or certificates that may have been in the stolen data.
Assess regulatory notification duties (GDPR, NIS2, sector regulators) — many carry a 72-hour reporting clock from awareness.
Monitor for the data appearing on Incransom's leak site and across paste and breach channels, and brief downstream partners who may be exposed through you.

How we know this. Darkfield monitors public ransomware leak sites continuously, archiving every new disclosure and the data later released against the victim. Each entry on this page is sourced from the operator's own publication and cross-checked against complementary OSINT feeds (RansomLook, ransomware.live, RansomWatch). We do not collect or host stolen data — only the metadata, timestamps and screenshots needed to make the public disclosure searchable and accountable. Records here are corrected when the original post is edited, retracted, or merged with another disclosure.